Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Anuh Pharma has informed that the Board of Directors of the Company at its Meeting held today Monday, 7th November, 2022, considered and approved the following agenda Items: The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th September, 2022. The Meeting of the Board of Directors commenced at 12:30 pm and concluded at 3:15 pm.
The above information is a part of company’s filings submitted to BSE.
